1. Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer
   Karolina Buszka et al, 2022, Cells CrossRef
2. The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments
   Daniel Di Capua et al, 2021, Cancers CrossRef
3. Double-Stranded DNA in Exosomes of Malignant Pleural Effusions as a Novel DNA Source for EGFR Mutation Detection in Lung Adenocarcinoma
   Xueling Qu et al, 2019, Frontiers in Oncology CrossRef
4. Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer
   Eva Obermayr et al, 2021, Journal of Personalized Medicine CrossRef
5. Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study
   Shih-Hong Li et al, 2022, International Journal of Molecular Sciences CrossRef
6. Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges
   Erika Rijavec et al, 2019, Cancers CrossRef
7. Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
   Connor O’Leary et al, 2020, Pharmaceuticals CrossRef